Medical Necessity Appeals: Criteria and Dispute Strategies

Medical necessity denials are the single most common basis for health insurance claim rejection in the United States, affecting millions of policyholders annually across commercial, Medicare, and Medicaid plans. This page covers the governing criteria that define medical necessity, the procedural mechanics of appealing such denials, the regulatory frameworks that establish appeal rights, and the classification boundaries that shape how different disputes are handled. Understanding these structures is essential for policyholders, clinicians, and patient advocates navigating a denial after treatment has been recommended or rendered.


Definition and scope

Medical necessity is a contractual and regulatory standard used by health insurers to determine whether a specific service, procedure, medication, or device warrants coverage under a given plan. The term does not have a single federal statutory definition that applies uniformly across all insurance markets. Instead, it is defined by a combination of plan contract language, insurer clinical criteria, and governing law.

The Affordable Care Act (ACA) established baseline protections for appeals of adverse benefit determinations, including medical necessity denials, under 42 U.S.C. § 300gg-19 and implementing regulations at 45 C.F.R. § 147.136. For employer-sponsored plans governed by the Employee Retirement Income Security Act (ERISA), medical necessity determinations are subject to the claims and appeals regulations at 29 C.F.R. § 2560.503-1. Medicare's standard, articulated in 42 C.F.R. § 411.15, requires services to be "reasonable and necessary for the diagnosis or treatment of illness or injury."

Because definition language varies by plan and market, the scope of a medical necessity appeal depends heavily on which regulatory regime governs the underlying coverage. As detailed in the insurance appeals process overview, the applicable framework determines which procedural rights attach and which external review mechanisms are available.


Core mechanics or structure

A medical necessity appeal follows a structured sequence mandated by federal and, in some cases, state law. Under ACA-compliant plans, insurers must provide at least one internal appeal level before a claimant may access external review. ERISA plans are similarly required to exhaust internal remedies before federal court access becomes available.

Internal appeal: The claimant submits a written challenge to the insurer's adverse benefit determination. Under 29 C.F.R. § 2560.503-1(f), urgent care claims must receive an internal appeal decision within 72 hours; non-urgent pre-service claims within 30 days; and post-service claims within 60 days.

External review: After exhausting internal appeals — or when an insurer fails to follow required timelines — claimants may access independent review. The ACA established a federal external review standard at 45 C.F.R. § 147.138 that applies to non-grandfathered plans not subject to a state external review law meeting federal standards. Independent Review Organizations (IROs) conduct these reviews; they are accredited bodies distinct from the insurer. The external review process provides a binding or, in some jurisdictions, non-binding decision depending on governing law.

Medicare: Medicare Part A and Part B appeals follow a five-level process defined by 42 C.F.R. Part 405, beginning with redetermination by the Medicare Administrative Contractor (MAC), then reconsideration by a Qualified Independent Contractor (QIC), then an Administrative Law Judge (ALJ) hearing, then the Medicare Appeals Council, and finally federal district court for claims meeting the jurisdictional threshold (set at $1,870 for ALJ hearings as of the 2024 threshold published by CMS).

Medicaid: Medicaid appeals are governed by state Medicaid agency procedures under 42 C.F.R. Part 431, which requires a fair hearing process. Managed Medicaid plans may add an internal appeal level before the state fair hearing.


Causal relationships or drivers

Medical necessity denials originate from a discrete set of identifiable conditions within the coverage determination process.

Clinical criteria mismatches: Most commercial insurers use proprietary clinical criteria guidelines — products from organizations such as InterQual (part of Change Healthcare/Optum) or Milliman Care Guidelines (MCG) — to benchmark whether a treatment meets necessity thresholds. When a treating physician's documentation does not map to those criteria, denial follows even if the clinical rationale is sound from a medical standpoint.

Incomplete documentation: A significant share of medical necessity denials are attributable to missing or ambiguous clinical records rather than to a genuine absence of clinical justification. The American Medical Association (AMA) has identified documentation gaps as a primary driver of prior authorization denials, which frequently precede necessity disputes.

Experimental or investigational classification: Insurers may deny a service as not medically necessary by classifying it as experimental — a separate but closely related determination. This classification can be contested through a dedicated pathway; see experimental treatment appeals for the distinct criteria that apply.

Plan benefit design: Medical necessity standards in a plan's Summary Plan Description (SPD) or Certificate of Coverage may be more restrictive than the treating physician's recommendation. Under ERISA, plan administrators are granted discretionary authority to interpret plan terms in many cases, which affects the standard of judicial review.

Parity violations: For mental health and substance use disorder services, federal Mental Health Parity and Addiction Equity Act (MHPAEA) requirements (29 U.S.C. § 1185a) prohibit insurers from applying more restrictive medical necessity criteria to behavioral health benefits than to comparable medical/surgical benefits. Parity violations are a documented driver of improper necessity denials, as analyzed in the appeals for denied mental health claims topic.


Classification boundaries

Medical necessity appeals fall into four primary categories, each with distinct procedural implications:

  1. Pre-service (prior authorization) denials: The insurer denies a request before treatment occurs. These disputes carry the highest urgency because delay affects patient care. The prior authorization denials and appeals page covers this category in depth.

  2. Post-service (claim) denials: Treatment has already occurred and the resulting claim is denied on necessity grounds. The claimant must document that the service met necessity criteria at the time it was rendered.

  3. Concurrent review denials: During an inpatient stay, an insurer terminates approval for continued hospitalization. These trigger expedited review rights under federal regulations.

  4. Retrospective denials: An insurer reverses a prior authorization or initial payment after the fact, asserting that the service was not medically necessary at the time of service.

The governing regulatory regime — ACA marketplace plan, ERISA employer-sponsored plan, Medicare, or Medicaid — establishes which of these subtypes receive expedited appeal rights and which timelines apply. State-law protections may provide additional rights for fully insured plans; self-funded ERISA plans are generally exempt from state insurance mandates by ERISA preemption.


Tradeoffs and tensions

Proprietary criteria vs. clinical judgment: Insurers' use of proprietary clinical criteria (InterQual, MCG) creates structural tension between standardized cost benchmarking and individualized clinical judgment. Courts in multiple jurisdictions have examined whether plan administrators may deny claims solely by reference to such criteria without independent physician review, and results have varied by circuit. The ERISA appeals framework governs the standard of review.

Exhaustion requirement vs. patient urgency: The procedural requirement to exhaust internal appeals before external review or litigation can impose clinically significant delays. Federal regulations mitigate this through expedited timelines — 72 hours for urgent pre-service appeals — but operationalizing those timelines reliably remains contested.

Discretionary authority clauses: Under ERISA, plans that grant administrators explicit discretionary authority to interpret plan terms receive deferential "abuse of discretion" judicial review rather than de novo review. California, Illinois, and 19 other states have enacted regulations or statutes prohibiting such clauses in fully insured plans, creating a bifurcated legal landscape.

Independent review binding effect: External review decisions are binding on the insurer under federal standards for non-grandfathered, non-ERISA plans. For ERISA plans subject to the DOL voluntary external review framework, the binding effect is less clearly established by statute, creating litigation uncertainty.


Common misconceptions

Misconception: A physician's recommendation automatically establishes medical necessity.
Correction: Physician recommendation is a necessary but not sufficient condition. Insurers apply their own clinical criteria, and plan language may define necessity more narrowly than a treating clinician's professional judgment. The physician's documentation must affirmatively address the insurer's specific criteria, not merely assert that treatment is appropriate.

Misconception: Losing an internal appeal forecloses further options.
Correction: Internal appeal exhaustion is the threshold for external review and, for ERISA plans, federal court access. External IRO decisions overturn insurer denials at substantial rates; a 2022 analysis by state insurance regulators across participating states found that policyholders who pursued external review prevailed in a material proportion of cases, though rates vary by state and service type.

Misconception: Medical necessity and benefit coverage are the same determination.
Correction: A service may be medically necessary but still excluded from coverage as a benefit design exclusion (e.g., cosmetic procedures, fertility treatment in states without mandates). These are distinct determinations requiring separate dispute strategies.

Misconception: ERISA plans have fewer appeal rights than ACA marketplace plans.
Correction: ERISA plans are subject to robust DOL claims and appeals regulations (29 C.F.R. § 2560.503-1), including specific notice, timing, and documentation requirements. The distinction is that ERISA plans are exempt from state insurance law mandates, not from federal procedural protections.

Misconception: External review is only available after years of internal appeals.
Correction: Under 45 C.F.R. § 147.138, a claimant may bypass internal appeals and go directly to external review if the plan fails to follow required internal appeal procedures in any material respect.


Checklist or steps (non-advisory)

The following sequence reflects the procedural stages in a medical necessity appeal under federal standards. Individual plan terms, governing law, and state regulations may add or modify steps.

  1. Obtain the denial notice — Confirm the stated reason is medical necessity (not a benefit exclusion or eligibility denial). Under 29 C.F.R. § 2560.503-1(g), denial notices must state the specific reason and reference the plan provision relied upon.

  2. Request the claim file and clinical criteria — Plans are obligated to provide, upon request, copies of the clinical guidelines, criteria, or protocols used to make the determination.

  3. Identify the applicable regulatory regime — Determine whether the plan is ACA marketplace, fully insured state-regulated, ERISA self-funded, Medicare, or Medicaid. Each has distinct timelines and appeal levels.

  4. Note the appeal deadline — ACA-compliant plans require at least 180 days to file an internal appeal from receipt of the denial notice (45 C.F.R. § 147.136). ERISA plans must provide at least 180 days. Missing this deadline may forfeit appeal rights.

  5. Compile clinical documentation — Gather treating physician notes, diagnostic results, treatment history, research-based literature supporting the treatment, and any prior authorization correspondence. The evidence required for insurance appeals page describes documentation standards.

  6. Request peer-to-peer review — In pre-service denials, the treating physician may request direct communication with the insurer's medical reviewer. Many insurers permit this before the formal internal appeal is adjudicated.

  7. Submit the internal appeal in writing — Address each specific criterion cited in the denial. Reference plan language, clinical guidelines, and MHPAEA parity requirements if applicable. Guidance on structuring this document appears at writing an insurance appeal letter.

  8. Track the decision deadline — Note applicable timelines (72 hours/urgent; 30 days/pre-service; 60 days/post-service under ERISA). If the insurer misses its deadline, the claimant may be deemed to have exhausted internal remedies.

  9. Request external review upon adverse internal determination — File with an IRO or state-designated reviewer. The independent review organizations page covers accreditation and selection.

  10. Escalate to state or federal regulators if procedures are violatedState insurance department appeals and the DOL Employee Benefits Security Administration (EBSA) accept complaints regarding procedural violations.


Reference table or matrix

Plan Type Governing Law Internal Appeal Levels External Review Binding on Insurer? Key Deadline (Post-service)
ACA Marketplace (non-grandfathered) 45 C.F.R. § 147.136 1 level minimum Federal/state IRO Yes 180 days from denial
ERISA Self-Funded 29 C.F.R. § 2560.503-1 1–2 levels DOL voluntary framework (state laws preempted) Variable 180 days from denial
Fully Insured (state-regulated) State law + ACA 1–2 levels State IRO or state insurance department Yes (most states) Varies by state (commonly 180 days)
Medicare Part A/B 42 C.F.R. Part 405 5 levels (MAC → QIC → ALJ → Council → Court) Administrative law process Yes 120 days for redetermination
Medicare Advantage 42 C.F.R. Part 422 Organization determination → IRE → ALJ → Council → Court Integrated within 5-level process Yes 60 days for initial appeal
Medicaid (FFS) 42 C.F.R. Part 431 State agency fair hearing State-specific Yes Varies by state
Medicaid Managed Care 42 C.F.R. Part 438 (as amended, eff. 2026-02-25) Plan internal appeal → state fair hearing; plans must provide independent medical review for certain denials State-specific; enhanced network adequacy and access standards apply Yes 60 days (plan internal appeal); expedited appeals available within 72 hours for urgent care

MHPAEA applicability: All plan types above, except grandfathered individual market plans, are subject to Mental Health Parity and Addiction Equity Act parity requirements for behavioral health necessity criteria (29 U.S.C. § 1185a).

References

📜 13 regulatory citations referenced  ·  ✅ Citations verified Feb 26, 2026  ·  View update log

Explore This Site